Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History DVAX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics DVAX

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Dynavax Technologies Corporation

DVAX
Current price
10.67 USD -0.04 USD (-0.37%)
Last closed 10.67 USD
ISIN US2681582019
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 1 308 883 584 USD
Yield for 12 month +2.40 %
1Y
3Y
5Y
10Y
15Y
DVAX
21.11.2021 - 28.11.2021

Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally. The company offers HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in adults aged 18 years and older; and CpG 1018, the adjuvant used in HEPLISAV-B. It also develops rF1V, a plague vaccine candidate in Phase 2 clinical trial; and Z-1018, an investigational vaccine candidate in Phase 1/2 clinical trial for the prevention of shingles in adults aged 50 years and older, as well as HEPLISAV-B for adults on hemodialysis. The company sells its products to hospitals and clinics, integrated delivery networks, public health clinics and prisons, the Department of Defense, the Department of Veterans Affairs, and retail pharmacies through wholesalers and specialty distributors. It has a collaboration agreement with the U.S. Department of Defense; Coalition for Epidemic Preparedness Innovations; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; and Biological E. Limited. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California. Address: 2100 Powell Street, EmeryVille, CA, United States, 94608

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

23.28 USD

P/E Ratio

Dividend Yield

Financials DVAX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures DVAX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+277 246 000 USD

Last Year

+232 284 000 USD

Current Quarter

+68 164 000 USD

Last Quarter

+72 032 000 USD

Current Year

+227 801 000 USD

Last Year

+182 117 000 USD

Current Quarter

+54 395 000 USD

Last Quarter

+58 622 000 USD
EBITDA 3 535 000 USD
Operating Margin TTM -31.40 %
Price to Earnings
Return On Assets TTM -0.070 %
PEG Ratio
Return On Equity TTM -10.45 %
Wall Street Target Price 23.28 USD
Revenue TTM 294 620 000 USD
Book Value 4.29 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 34.20 %
Dividend Yield
Gross Profit TTM 177 612 992 USD
Earnings per share -0.49 USD
Diluted Eps TTM -0.49 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY 20.80 %
Profit Margin -20.39 %

Stock Valuation DVAX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 29.24
Enterprise Value Revenue 3.17
Price Sales TTM 4.44
Enterprise Value EBITDA 30.92
Price Book MRQ 2.47

Technical Indicators DVAX

For 52 Weeks

9.22 USD 14.63 USD
50 Day MA 10.16 USD
Shares Short Prior Month 15 169 101
200 Day MA 11.86 USD
Short Ratio 8.99
Shares Short 15 158 370
Short Percent 18.80 %